| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 63014-08-4 | DNP-PRO-GLN-GLY-Ile-Ala-GLY-GLN-D-ARG | DNP-PRO-GLN-GLY-Ile-Ala-GLY-GLN-D-ARG-OH; DNP-PRO-GLN-GLY-Ile-Ala-GLY-GLN-D-ARG; DNP-PRO-GLN-GLY-Ile-Ala-GLY-GLN-D-ARG-OH; DNP-PQGIAGQ-D-R; COLLAGENASE SUBSTRATE I; 2,4-DINITROPHENYL-L-PROLYL-L-GLUTAMINYLGLYCYL-L-ISOLEUCYL-L-ALANYLGLYCYL-L-GLUTAMINYL-D-ARGININE; 2,4-DINITROPHENYL-PRO-GLN-GLY-Ile-Ala-GLY-GLN-D-ARG-OH; N2-[N2-[N-[N-[N-[N-[N2-[1-(2,4-dinitrophenyl)-L-prolyl]-L-glutaminyl]glycyl]-L-isoleucyl]-L-alanyl]glycyl]-L-glutaminyl]-D-arginine; DNP-peptide |  | C40H61N15O15 | 详情 | 供应商 |
| 81117-26-2 | H-LYS-ARG-ASN-LYS-ASN-ASN-Ile-Ala-OH | H-LYS-ARG-ASN-LYS-ASN-ASN-Ile-Ala-OH; GLUCAGON FRAGMENT 30-37; H-LYS-ARG-ASN-LYS-ASN-ASN-Ile-Ala-OH; glucagon 37 fragment 30-37; glicentin (62-69) |  | C39H72N16O12 | 详情 | 供应商 |
| 198694-74-5 | H-LYS-ARG-ARG-TRP-LYS-LYS-ASN-PHE-Ile-Ala-VAL-NH2; MYOSIN LIGHT CHAIN KINASE INHIBITOR; MYOSIN LIGHT CHAIN KINASE (342-352) AMIDE; MLCK INHIBITOR PEPTIDE; H-LYS-ARG-ARG-TRP-LYS-LYS-ASN-PHE-Ile-Ala-VAL-NH2; LYS-ARG-ARG-TRP-LYS-LYS-ASN-PHE-Ile-Ala-VAL-NH2 |  | C68H113N23O12 | 详情 | 供应商 | |
| 99534-03-9 | THR-THR-TYR-ALA-ASP-PHE-Ile-Ala-SER-GLY-ARG-THR-GLY-ARG-ARG-ASN-ALA-ILE-HIS-ASP; THR-THR-TYR-ALA-ASP- | H-THR-THR-TYR-ALA-ASP-PHE-Ile-Ala-SER-GLY-ARG-THR-GLY-ARG-ARG-ASN-ALA-ILE-HIS-ASP-OH; H-TTYADFIASGRTGRRNAIHD; H-THR-THR-TYR-ALA-ASP-PHE-Ile-Ala-SER-GLY-ARG-THR-GLY-ARG-ARG-ASN-ALA-ILE-HIS-ASP-OH; CAMP DEPENDENT PK INHIBITOR (5-24); CAMP-DEPENDENT PROTEIN KINASE INHIBITOR (5-24); CAMP-DEPENDENT PROTEIN KINASE INHIBITOR-ALPHA (5-24) (HUMAN, MOUSE, RABBIT, RAT); ip20; TTYADFIASGRTGRRNAIHD; THR-THR-TYR-ALA-ASP-PHE-Ile-Ala-SER-GLY-ARG-THR-GLY-ARG-ARG-ASN-ALA-ILE-HIS-ASP |  | C94H148N32O31 | 详情 | 供应商 |
| 126103-95-5 | N-SUCCINYL-Ile-Ala 7-AMIDO-4-METHYLCOUMARIN; N-SUCCINYL-Ile-Ala 7-AMIDO-4-METHYLCOUMARIN; SUCCINYL-L-ISOLEUCYL-L-ALANINE 4-METHYLCOUMARYL-7-AMIDE; SUC-Ile-Ala-AMC; SUC-Ile-Ala-MCA |  | C23H29N3O7 | 详情 | 供应商 | |
| 102068-15-5 | PGLA | Gly-Met-Ala-Ser-Lys-Ala-Gly-Ala-Ile-Ala-Gly-Lys-Ile-Ala-Lys-Val-Ala-Leu-Lys-Ala-Leu-NH2; peptide-Gly-Leu-amide |  | C88H162N26O22S | 详情 | 供应商 |
| 112540-82-6 | ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-Ile-Ala-GLU-ILE-HIS-THR-ALA; ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-Ile-Ala-GLU-ILE-HIS-THR-ALA; ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-Ile-Ala-GLU-ILE-HIS-THR-ALA-NH2: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2; ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-Ile-Ala-GLU-ILE-HIS-THR-ALA: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA | H-ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-Ile-Ala-GLU-ILE-HIS-THR-ALA-OH; AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA; AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2; H-ALA-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-ILE-GLN-ASP-LEU-ARG-ARG-ARG-PHE-PHE-LEU-HIS-HIS-LEU-Ile-Ala-GLU-ILE-HIS-THR-ALA-OH; HUMORAL HYPERCALCEMIA OF MALIGNANCY FACTOR, (1-34), HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) AMIDE (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR FRAGMENT 1-34 AMIDE HUMAN | 无 | C180H287N57O48 | 详情 | 供应商 |
sitemap.xml